Skip to main content Skip to section navigation Skip to footer
Back to scorpiusbiologics.com
Scorpius Holdings, Inc. Home
Investor Relations
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • At-a-Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Back to scorpiusbiologics.com

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 16, 2022 4:44 pm EDT

NightHawk Biosciences Provides First Quarter 2022 Business Update

May 10, 2022 8:00 am EDT

NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35

May 03, 2022 7:00 am EDT

Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today

Apr 27, 2022 8:00 am EDT

Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian Government

Apr 20, 2022 8:00 am EDT

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

Apr 19, 2022 11:00 am EDT

Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense Capabilities

Apr 18, 2022 4:00 pm EDT

REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest Developments

Apr 18, 2022 8:30 am EDT

Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility

Apr 14, 2022 12:35 pm EDT

Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest Developments

Mar 25, 2022 8:00 am EDT

Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing Process

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 35
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
©2025 Scorpius Holdings, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences